Microvascular Therapeutics
AZ - TucsonBiotechnology
Focus: Microvascular Therapeutics is a public biotechnology company focused on ultrasound contrast agents and theranostic technologies for cardiovascular disease. The company operates at modest scale with highly specialized technology in a niche therapeutic area.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Microvascular Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Microvascular Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
3 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Use of intermittent high MI impulses during echocardiogram
Acute Coronary SyndromeClinical Trials (1)
NCT00955136Utilization of Diagnostic Ultrasound in the Detection and Therapy of Acute Coronary Syndromes
N/AHelp build intelligence for Microvascular Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.